Delivery Order SPE2DE21D0005-SPE2D625F1PF5

Award Date 6/10/25
Potential Completion Date 6/16/25
Potential Value $1.7K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,118.88, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is a delivery order for PURAPLY AM (2x2) 4 SQ CM, a wound care product. Organogenesis is a key supplier of medical products designed to support wound healing and tissue regeneration for military personnel and veterans. The company has established itself as a provider of...
This federal contract award was made by the Medical Supply Chain division of the U.S. Defense Department to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $5,100 fixed-price delivery order, awarded on May 12, 2025, is for PURAPLY AM XT 4.91x4.91 wound dressings with an ultimate completion date of May 15, 2025. The contract does not utilize a set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis holds...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $8,500.00 fixed-price delivery order is for the procurement of medical supplies, specifically PURAPLY AM XT 4.91X4.91 wound dressings. The contract has a period of performance through July 23, 2024. Organogenesis is a long-standing federal contractor that specializes in the development and manufacture of advanced wound care and...
The Defense Logistics Agency Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company. The order is for PURAPLY AM (2x2) 4 sq cm, a wound care dressing product. Organogenesis Inc. has provided a variety of surgical implants, wound care dressings, and tissue regeneration products to federal agencies like the Department of Veterans Affairs and the Defense Logistics Agency through multiple...
This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine manufacturer based in Canton, Massachusetts. The contract is a delivery order for PURAPLY AM XT 4.91X4.91 wound dressings, which are used for advanced wound care. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and the DLA, including a $25 million...
This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order is for PURAPLY AM wound care dressings, which are advanced skin substitutes used to support tissue repair and regeneration. Organogenesis is an experienced federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA...
This is a $1,678.32 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is for the supply of PURAPLY AM (2x2) 4 sq cm wound care dressings, with a period of performance through June 4, 2024. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $49.5 million multiple-award IDC with the DLA for...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment, with a completion date of March 20, 2025. The contract does not have a set-aside...
The Defense Logistics Agency Troop Support Medical awarded a fixed-price delivery order to Organogenesis Inc., a leading regenerative medicine company, for the supply of PURAPLY AM wound dressings. The delivery order has a potential value of $1,118.88 and a completion date of February 26, 2024. Organogenesis Inc. has previously been awarded several Indefinite Delivery Vehicles (IDVs) by the Department of Veterans Affairs (VA) and the Defense Logistics Agency to provide a range of regenerative...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract is a $1,140 fixed-price delivery order for PURAPLY MZ 500MG, a wound care product. The contract is not associated with a set-aside program and has an ultimate completion date of April 8, 2025. Organogenesis Inc. is a for-profit manufacturer that specializes in advanced wound care, surgical...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F1PF5
    Delivery Order

This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, to provide PURAPLY AM wound dressings to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,678.32 fixed-price with economic price adjustment delivery order has a period of performance through June 16, 2025. Organogenesis is an established supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies, including the Department of Veterans Affairs (VA) and DLA. The company holds several significant federal Indefinite Delivery Vehicles (IDVs) worth up to $49.5 million for wound care dressings and medical supplies. This award does not utilize a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. The contract supports the provision of specialized medical supplies to military personnel and veterans through the DLA's medical supply chain.

Generated 9/9/25, 12:53 PM